Get the Stockscreener App
29.22
4.63%
-1.42
After Hours:
28.87
-0.35
-1.20%
Avidity Biosciences Inc Stock (RNA) Latest News
Avidity Biosciences (NASDAQ:RNA) Receives "Buy" Rating from Chardan Capital - MarketBeat
Avidity Biosciences Full Year 2024 Earnings: Revenues Beat Expectations, EPS In Line - Yahoo Finance UK
Barclays Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $57.00 - MarketBeat
Handelsbanken Fonder AB Invests $788,000 in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences Advances RNA Therapeutics for Rare Diseases - TipRanks
Avidity Biosciences (NASDAQ:RNA) Issues Quarterly Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
Positive Outlook for Avidity Biosciences Driven by Promising Pipeline Developments and Strong Financial Position - TipRanks
Avidity Biosciences: Promising Drug Pipeline and Potential Approval for DMD44 Drive Buy Rating - TipRanks
How Is Avidity Biosciences Fighting for Rare Disease Patients Beyond Drug Development? - StockTitan
Cantor Fitzgerald maintains $96 target on Avidity Biosciences stock By Investing.com - Investing.com UK
Avidity Biosciences Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga
RBC Cuts Price Target on Avidity Biosciences to $61 From $67, Keeps Outperform, Speculative Risk - Marketscreener.com
Why Avidity Biosciences Shares Are Under the Spotlight - TipRanks
Avidity Biosciences: Promising Clinical Developments and Strong Financial Position Justify Buy Rating - TipRanks
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates - MSN
Avidity Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Avidity Biosciences, Inc. SEC 10-K Report - TradingView
Avidity Biosciences reports Q4 EPS (80c), consensus (78c) - TipRanks
Avidity Biosciences Reports Fourth Quarter 2024 Financial Results and Recent Highlights - PR Newswire
Avidity Biosciences to Participate in Upcoming Investor Conferences - BioSpace
Avidity Biosciences: Looks Tempting, But Wait For Interim Phase 3 Data (NASDAQ:RNA) - Seeking Alpha
Insiders At Avidity Biosciences Sold US$1.0m In Stock, Alluding To Potential Weakness - Simply Wall St
Avidity Biosciences (RNA) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Avidity Biosciences Announces Inducement Grants -February 21, 2025 at 05:50 pm EST - Marketscreener.com
Avidity Biosciences Announces Inducement Grants - TradingView
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Financial Times
Avidity Biosciences, Inc. (NASDAQ:RNA) Given Average Rating of "Buy" by Analysts - MarketBeat
Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com
(RNA) Proactive Strategies - Stock Traders Daily
Legato Capital Management LLC Invests $301,000 in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Stock Price Down 7%Here's Why - MarketBeat
abrdn plc Boosts Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Kathleen P. Gallagher Sells 5,875 Shares - MarketBeat
(RNA) Investment Report - Stock Traders Daily
RNA Drug Development Pioneer Joins Codexis: Oligonucleotide Expert Who Created First Approved Antisense Drugs - StockTitan
Avidity Biosciences chief program officer sells $188,918 in stock - MSN
Avidity Biosciences chief program officer sells $188,918 in stock By Investing.com - Investing.com UK
We're Hopeful That Avidity Biosciences (NASDAQ:RNA) Will Use Its Cash Wisely - Yahoo Finance
How to Take Advantage of moves in (RNA) - Stock Traders Daily
Avidity Biosciences (NASDAQ:RNA) Stock Price Up 6%Here's Why - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Recommendation of "Buy" from Analysts - MarketBeat
Avidity Biosciences CEO Sarah Boyce sells $297k in stock - MSN
Avidity Biosciences' chief medical officer sells shares totaling $112,856 - MSN
Assenagon Asset Management S.A. Invests $1.18 Million in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock - MSN
Avidity Biosciences chief scientific officer sells shares worth $162,191 - MSN
Avidity Biosciences director sells $53,536 in stock - MSN
Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 3,287 Shares - MarketBeat
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 2,959 Shares of Stock - MarketBeat
Sarah Boyce Sells 10,397 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $84,611 in stock By Investing.com - Investing.com Canada
Arthur A. Levin Sells 1,872 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock - MarketBeat
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):